- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x HF4: 4-amino-1-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}pyrimidin-2(1H)-one(Non-covalent)
- 4 x DTP: 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE(Non-covalent)
DTP.2: 19 residues within 4Å:- Chain A: R.257, F.261, R.276, K.278, N.282, K.447
- Chain B: V.41, I.42, N.43, H.49
- Chain C: V.80, F.81, I.249, R.296, H.300, K.301, V.302
- Ligands: MG.7, GTP.8
22 PLIP interactions:8 interactions with chain C, 12 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: C:V.80, C:F.81
- Hydrogen bonds: C:R.296, A:R.257, A:N.282, B:N.43, B:N.43
- Salt bridges: C:H.300, C:H.300, C:K.301, C:K.301, C:K.301, A:R.257, A:R.276, A:K.278, A:K.278, A:K.278, A:K.447
- Water bridges: A:R.276, A:K.278
- pi-Cation interactions: A:R.257, A:R.257
DTP.9: 19 residues within 4Å:- Chain A: V.41, I.42, N.43, H.49
- Chain B: R.257, F.261, R.276, K.278, N.282, K.447
- Chain D: V.80, F.81, I.249, R.296, H.300, K.301, V.302
- Ligands: MG.3, GTP.4
22 PLIP interactions:7 interactions with chain D, 13 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: D:V.80, D:F.81
- Salt bridges: D:H.300, D:H.300, D:K.301, D:K.301, D:K.301, B:R.257, B:R.276, B:K.278, B:K.278, B:K.278, B:K.447
- Hydrogen bonds: B:R.257, B:N.282, B:N.282, A:N.43, A:N.43
- Water bridges: B:R.276, B:K.278
- pi-Cation interactions: B:R.257, B:R.257
DTP.11: 19 residues within 4Å:- Chain A: V.80, F.81, I.249, R.296, H.300, K.301, V.302
- Chain C: R.257, F.261, R.276, K.278, N.282, K.447
- Chain D: V.41, I.42, N.43, H.49
- Ligands: MG.15, GTP.16
21 PLIP interactions:12 interactions with chain C, 7 interactions with chain A, 2 interactions with chain D- Hydrogen bonds: C:R.257, C:N.282, C:N.282, D:N.43, D:N.43
- Water bridges: C:R.276
- Salt bridges: C:R.257, C:R.276, C:K.278, C:K.278, C:K.278, C:K.447, A:H.300, A:H.300, A:K.301, A:K.301, A:K.301
- pi-Cation interactions: C:R.257, C:R.257
- Hydrophobic interactions: A:V.80, A:F.81
DTP.17: 18 residues within 4Å:- Chain B: V.80, F.81, R.296, H.300, K.301, V.302
- Chain C: V.41, I.42, N.43, H.49
- Chain D: R.257, F.261, R.276, K.278, N.282, K.447
- Ligands: GTP.12, MG.18
23 PLIP interactions:2 interactions with chain C, 15 interactions with chain D, 6 interactions with chain B- Hydrogen bonds: C:N.43, C:N.43, D:R.257, D:N.282, D:N.282
- Water bridges: D:R.257, D:R.257, D:K.278, D:K.278
- Salt bridges: D:R.257, D:R.276, D:K.278, D:K.278, D:K.278, D:K.447, B:H.300, B:H.300, B:K.301, B:K.301
- pi-Cation interactions: D:R.257, D:R.257
- Hydrophobic interactions: B:V.80, B:F.81
- 8 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 3 residues within 4Å:- Chain A: K.40
- Ligands: GTP.4, DTP.9
No protein-ligand interaction detected (PLIP)MG.5: 3 residues within 4Å:- Chain A: D.233, K.236
- Ligands: HF4.1
No protein-ligand interaction detected (PLIP)MG.7: 3 residues within 4Å:- Chain B: K.40
- Ligands: DTP.2, GTP.8
No protein-ligand interaction detected (PLIP)MG.10: 3 residues within 4Å:- Chain B: R.130, S.226
- Ligands: HF4.6
No protein-ligand interaction detected (PLIP)MG.14: 3 residues within 4Å:- Chain C: D.235, K.236
- Ligands: HF4.13
No protein-ligand interaction detected (PLIP)MG.15: 4 residues within 4Å:- Chain C: K.447
- Chain D: K.40
- Ligands: DTP.11, GTP.16
No protein-ligand interaction detected (PLIP)MG.18: 3 residues within 4Å:- Chain D: K.447
- Ligands: GTP.12, DTP.17
No protein-ligand interaction detected (PLIP)MG.20: 3 residues within 4Å:- Chain D: D.233, K.236
- Ligands: HF4.19
No protein-ligand interaction detected (PLIP)- 4 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
GTP.4: 16 residues within 4Å:- Chain A: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Chain B: K.447
- Chain D: Y.79, V.80, V.302, R.375, K.379
- Ligands: MG.3, DTP.9
15 PLIP interactions:5 interactions with chain D, 8 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: D:R.375, A:V.41, A:Q.66, A:R.69
- Salt bridges: D:R.375, D:K.379, D:K.379, A:K.40, A:K.40, A:K.40, A:D.61, B:K.447, B:K.447
- pi-Cation interactions: D:R.375
- Water bridges: A:K.40
GTP.8: 16 residues within 4Å:- Chain A: K.447
- Chain B: K.40, V.41, I.42, V.57, I.60, D.61, Q.66, R.69, F.89
- Chain C: Y.79, V.80, V.302, R.375
- Ligands: DTP.2, MG.7
16 PLIP interactions:5 interactions with chain C, 9 interactions with chain B, 2 interactions with chain A- Water bridges: C:R.375, B:K.40, B:Q.66
- Salt bridges: C:R.375, C:K.379, C:K.379, B:K.40, B:K.40, B:K.40, B:D.61, A:K.447, A:K.447
- pi-Cation interactions: C:R.375
- Hydrogen bonds: B:V.41, B:Q.66, B:R.69
GTP.12: 16 residues within 4Å:- Chain B: Y.79, V.80, V.302, R.375, K.379
- Chain C: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Chain D: K.447
- Ligands: DTP.17, MG.18
16 PLIP interactions:9 interactions with chain C, 5 interactions with chain B, 2 interactions with chain D- Hydrogen bonds: C:V.41, C:Q.66, C:R.69, B:R.375
- Water bridges: C:K.40, C:D.61
- Salt bridges: C:K.40, C:K.40, C:K.40, C:D.61, B:R.375, B:K.379, B:K.379, D:K.447, D:K.447
- pi-Cation interactions: B:R.375
GTP.16: 16 residues within 4Å:- Chain A: Y.79, V.80, V.302, R.375, K.379
- Chain C: K.447
- Chain D: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Ligands: DTP.11, MG.15
17 PLIP interactions:11 interactions with chain D, 2 interactions with chain C, 4 interactions with chain A- Hydrogen bonds: D:V.41, D:Q.66, D:R.69
- Water bridges: D:K.40, D:K.40, D:D.61, D:Q.66
- Salt bridges: D:K.40, D:K.40, D:K.40, D:D.61, C:K.447, C:K.447, A:R.375, A:K.379, A:K.379
- pi-Cation interactions: A:R.375
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Knecht, K.M. et al., The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-10-10
- Peptides
- Deoxynucleoside triphosphate triphosphohydrolase SAMHD1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
CC
BD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x HF4: 4-amino-1-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}pyrimidin-2(1H)-one(Non-covalent)
- 4 x DTP: 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE(Non-covalent)
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 4 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Knecht, K.M. et al., The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-10-10
- Peptides
- Deoxynucleoside triphosphate triphosphohydrolase SAMHD1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
CC
BD
A